193 related articles for article (PubMed ID: 19375814)
1. Activity of pemetrexed against brain metastases in a patient with adenocarcinoma of the lung.
Omlin A; D'Addario G; Gillessen S; Cerny T; von Hessling A; Früh M
Lung Cancer; 2009 Sep; 65(3):383-4. PubMed ID: 19375814
[TBL] [Abstract][Full Text] [Related]
2. Major and prolonged response to pemetrexed in two cases of lung adenocarcinoma with bronchioloalveolar carcinoma features.
Duruisseaux M; Cadranel J; Biron E; Pérol M; Guérin JC; Arpin D
Lung Cancer; 2009 Sep; 65(3):385-7. PubMed ID: 19346028
[TBL] [Abstract][Full Text] [Related]
3. [Long-term survival of patient with brain metastases from lung cancer treated by pemetrexed monotherapy].
Ito S; Ogawa Y; Harada H; Yamaguchi T; Munakata K
Gan To Kagaku Ryoho; 2012 May; 39(5):793-6. PubMed ID: 22584333
[TBL] [Abstract][Full Text] [Related]
4. A phase I/II study of neoadjuvant chemotherapy with Pemetrexed (Alimta) in rectal cancer.
Derwinger K; Kodeda K; Swartling T; Kälebo P; Carlsson G; Gustavsson B
Eur J Surg Oncol; 2011 Jul; 37(7):583-8. PubMed ID: 21550200
[TBL] [Abstract][Full Text] [Related]
5. Pemetrexed-induced eyelid edema in lung cancer.
Martins-Filho PR; Kameo SY; Mascarenhas-Oliveira AC; Vieira NF; Azevedo E
J Craniofac Surg; 2013 Jul; 24(4):e401-3. PubMed ID: 23851735
[TBL] [Abstract][Full Text] [Related]
6. Activity of pemetrexed on brain metastases from non-small cell lung cancer: what is the mechanism?
Dogan M; Yalcin B; Utkan G; Urun Y; Ozal G
Lung Cancer; 2009 Dec; 66(3):399. PubMed ID: 19783320
[No Abstract] [Full Text] [Related]
7. Pemetrexed as a component of first-, second- and third- line chemotherapy in treating patients with metastatic lung adenocarcinoma.
Huang XE; Tian GY; Cao J; Xu X; Lu YY; Wu XY; Liu J; Shi L; Xiang J
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6663-7. PubMed ID: 24377585
[TBL] [Abstract][Full Text] [Related]
8. Pemetrexed-induced anaphylaxis.
Shah BK; Hewett Y
Acta Oncol; 2013 May; 52(4):881. PubMed ID: 23472834
[No Abstract] [Full Text] [Related]
9. Continuous pemetrexed treatment for brain metastasis in non-small cell lung cancer--a report of two cases.
Ochi N; Yamane H; Yamagishi T; Takigawa N
Lung Cancer; 2013 Apr; 80(1):111-3. PubMed ID: 23279874
[No Abstract] [Full Text] [Related]
10. [Second-line treatment of advanced non-small-cell lung cancer: role of pemetrexed].
Pérol M
Rev Pneumol Clin; 2005 Sep; 61(4 Pt 2):4S14-7. PubMed ID: 16273004
[No Abstract] [Full Text] [Related]
11. Successful treatment with pemetrexed in a patient with mucinous bronchioloalveolar carcinoma: long-term response duration with mild toxicity.
Okuda C; Kim YH; Takeuchi K; Togashi Y; Masago K; Sakamori Y; Mio T; Mishima M
J Thorac Oncol; 2011 Mar; 6(3):641-2. PubMed ID: 21317746
[No Abstract] [Full Text] [Related]
12. Pemetrexed-induced edema of the eyelid.
Kurata T; Tamura K; Okamoto I; Satoh T; Nakagawa K; Fukuoka M
Lung Cancer; 2006 Nov; 54(2):241-2. PubMed ID: 16996165
[TBL] [Abstract][Full Text] [Related]
13. Marked response to both S-1 and pemetrexed in a patient with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase-positive lung adenocarcinoma.
Kaneda H; Okamoto I; Sakai K; Tanizaki J; Takeda M; Nishio K; Nakagawa K
Acta Oncol; 2012 Sep; 51(7):942-4. PubMed ID: 22283471
[No Abstract] [Full Text] [Related]
14. [A case of lung cancer resistant to pemetrexed responding to S-1 monotherapy].
Oyamada Y; Maeshima A; Takeuchi K; Kato R
Gan To Kagaku Ryoho; 2013 Jun; 40(6):781-4. PubMed ID: 23863658
[TBL] [Abstract][Full Text] [Related]
15. Development and cross-validation of prognostic models to assess the treatment effect of cisplatin/pemetrexed chemotherapy in lung adenocarcinoma patients.
Mou W; Liu Z; Luo Y; Zou M; Ren C; Zhang C; Wen X; Wang Y; Tian Y
Med Oncol; 2014 Sep; 31(9):59. PubMed ID: 25119500
[TBL] [Abstract][Full Text] [Related]
16. [Muscle metastasis revealing bronchial adenocarcinoma].
Ketata W; Feki W; Msaad S; Yangui I; Ayoub A
Rev Mal Respir; 2011 Jan; 28(1):71-4. PubMed ID: 21277477
[TBL] [Abstract][Full Text] [Related]
17. [Pemetrexed: from preclinic to clinic].
Lansiaux A; Lokiec F
Bull Cancer; 2007; 94 Spec No Actualites():S134-8. PubMed ID: 17845983
[TBL] [Abstract][Full Text] [Related]
18. [Pemetrexed development in oncology].
Chaigneau L; Villanueva C; Thierry-Vuillemin A; Legat-Fagnoni C; N'Guyen T; Maurina T; Lorgis V; Pivot X
Bull Cancer; 2007; 94 Spec No Actualites():S142-8. PubMed ID: 17845985
[TBL] [Abstract][Full Text] [Related]
19. [Pneumocystis pneumonia in a patient treated with pemetrexed for non small cell lung cancer].
Neuville M; Borie R; Rodier JM; Debray MP; Danel C; Dombret MC; Aubier M; Crestani B
Rev Mal Respir; 2011 Jan; 28(1):97-100. PubMed ID: 21277483
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and efficacy of pemetrexed in patients with brain or leptomeningeal metastases.
Kumthekar P; Grimm SA; Avram MJ; Kaklamani V; Helenowski I; Rademaker A; Cianfrocca M; Gradishar W; Patel J; Mulcahy M; McCarthy K; Raizer JJ
J Neurooncol; 2013 Apr; 112(2):247-55. PubMed ID: 23354655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
